Get the Stockscreener App
0.0236
142.05%
0.0139
Windtree Therapeutics Inc stock is traded at $0.0236, with a volume of 128.96K.
It is up +142.05% in the last 24 hours and up +142.05% over the past month.
WINDTREE THERAPEUTICS NEW
See More
Previous Close:
$0.00975
Open:
$0.023
24h Volume:
128.96K
Relative Volume:
1.10
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-40.00M
P/E Ratio:
-0.00277
EPS:
-8.5112
Net Cash Flow:
$-15.12M
1W Performance:
+142.05%
1M Performance:
+142.05%
6M Performance:
-86.89%
1Y Performance:
-98.94%
1-Day Range:
$0.0205
$0.0249
1-Week Range:
$0.0205
$0.0249
52-Week Range:
$0.0081
$0.19
Windtree Therapeutics Inc Stock (WINT) Company Profile
Name
Windtree Therapeutics Inc
Sector
Industry
Phone
-
Address
-
Compare WINT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WINT
Windtree Therapeutics Inc
|
0.0236 | 0 | 0 | -40.00M | -15.12M | -8.5112 |
VRTX
Vertex Pharmaceuticals Inc
|
424.92 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
705.45 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
785.61 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.08 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
294.16 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Windtree Therapeutics Inc Stock (WINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-20 | Initiated | Ladenburg Thalmann | Buy |
Windtree Therapeutics Inc Stock (WINT) Latest News
WINT | WINDTREE THERAPEUTICS NEW Insider Trading - Quiver Quantitative
Drug developer emerges in Durham with former Windtree assets - The Business Journals
Earnings Beat: Is Windtree Therapeutics Inc a strong growth stock2026 AllTime Highs & Community Trade Idea Sharing Platform - baoquankhu1.vn
Windtree Therapeutics (WINT) Eps Diluted (TTM) - Zacks Investment Research
Windtree Therapeutics Delays Filing of Annual Report - TipRanks
What analysts say about Windtree Therapeutics Inc stockPortfolio Profit Report & Daily Stock Momentum Reports - baoquankhu1.vn
Windtree Therapeutics Stock Price Forecast. Should You Buy WINT? - StockInvest.us
Windtree (WINT) delays 2025 Form 10-K, expects to file by April 15, 2026 - Stock Titan
Windtree Therapeutics Stock: Clinical-Stage Biotech Focused on Respiratory Therapies Amid Volatile T - AD HOC NEWS
Windtree Therapeutics (WINT) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Windtree Therapeutics, Inc. (WINT) stock price, news, quote and history - Yahoo Finance Singapore
Market Moves: What analysts say about Windtree Therapeutics Inc stockTreasury Yields & Real-Time Stock Movement Alerts - baoquankhu1.vn
Windtree Therapeutics Secures $520 Million in Equity Agreements to Expand BNB Cryptocurrency Holdings - MSN
Can Windtree Therapeutics Inc sustain earnings growth2026 Short Interest & Precise Trade Entry Recommendations - baoquankhu1.vn
Earnings Beat: Is Windtree Therapeutics Inc a defensive stock2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Evofem (NASDAQ: EVFM) ends Windtree PHEXXI supply deal without termination fees - Stock Titan
Windtree Therapeutics Targets July for Interim Data from Key Cardiogenic Shock Study - MSN
Windtree Therapeutics Announces Promising Phase 2 Study Results for Istaroxime - MSN
CommLoan Achieves Nationwide Regulatory Approval Across All 50 States – Company Announcement - Financial Times
AI mortgage marketplace CommLoan goes nationwide, pursues reverse merger - Stock Titan
Windtree Therapeutics, Inc.Common Stock (NQ: WINT - The Chronicle-Journal
Breakout Move: What analysts say about Windtree Therapeutics Inc stock2026 EndofYear Setup & Weekly High Return Forecasts - baoquankhu1.vn
Scottsdale fintech CommLoan plans reverse merger - The Business Journals
Windtree Showcases Promising Istaroxime Data for Cardiogenic Shock at Major Conference - MSN
Aug Reactions: Is Windtree Therapeutics Incs growth already priced inQuarterly Market Summary & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Reactions: Is Windtree Therapeutics Inc stock influenced by commodity pricesFed Meeting & Verified Momentum Stock Watchlist - baoquankhu1.vn
Bearish Setup: Is Windtree Therapeutics Inc stock showing strong momentumInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Aug Drivers: Is Windtree Therapeutics Inc stock showing strong momentumJuly 2025 EndofMonth & Safe Entry Zone Tips - baoquankhu1.vn
Aug Macro: Is Windtree Therapeutics Inc stock showing strong momentumJuly 2025 Gainers & AI Powered Market Entry Strategies - baoquankhu1.vn
WINT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Breakout Zone: Is Windtree Therapeutics Inc stock showing strong momentumEarnings Recap Report & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Can Windtree Therapeutics Inc. deliver consistent dividendsRate Cut & Weekly Sector Rotation Insights - mfd.ru
Is Windtree Therapeutics Inc.’s growth already priced inMarket Risk Analysis & AI Based Buy and Sell Signals - mfd.ru
US Market Recap: Is Windtree Therapeutics Inc stock influenced by commodity prices - baoquankhu1.vn
Can Windtree Therapeutics Inc. stock surprise with earnings upside2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - mfd.ru
Retail Trends: Can Bandwidth Inc maintain its current growth rateTrade Entry Summary & Community Trade Idea Sharing - baoquankhu1.vn
WINTW Windtree Therapeutics (PNK) up 466.67% on 30 Jan 2026: thin-volume move to monitor - Meyka
Options Flow: Is Windtree Therapeutics Inc stock influenced by commodity prices2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Breakout Watch: Should you buy the dip on Seven Hills Realty TrustGap Down & Stock Portfolio Risk Management - baoquankhu1.vn
Meme Stocks: What analysts say about Windtree Therapeutics Inc stockWeekly Stock Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
How Windtree Therapeutics Inc. stock reacts to bond yieldsInterest Rate Changes & Grow Steadily With Our Wealth Roadmap - bollywoodhelpline.com
Resistance Check: Why Windtree Therapeutics Inc stock remains undervaluedTreasury Yields & AI Forecast for Swing Trade Picks - Bộ Nội Vụ
Windtree sells heart drug assets, keeps a cut of any future breakthrough - MSN
Earnings Recap: What analysts say about Windtree Therapeutics Inc stockMarket Risk Summary & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Published on: 2026-01-11 01:19:36 - Улправда
Windtree Therapeutics Announces Move into Cryptocurrency Payments and Holdings - MSN
Why Windtree Therapeutics Inc. stock is popular among millennials2025 Support & Resistance & AI Powered Market Trend Analysis - Улправда
Is Windtree Therapeutics Inc. stock trading near support levels2025 Fundamental Recap & Low Volatility Stock Recommendations - Улправда
Is Windtree Therapeutics Inc. stock supported by strong cash flowsQuarterly Risk Review & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Does Windtree Therapeutics Inc. stock trade at a discount to peers2025 Technical Patterns & AI Forecasted Entry and Exit Points - Улправда
How interest rate cuts could boost Windtree Therapeutics Inc. stockEarnings Risk Report & Free Growth Oriented Trading Recommendations - Улправда
Windtree Therapeutics Inc Stock (WINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
Cap:
|
Volume (24h):